A phase III open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator's choice in advanced melanoma patients progressing post anti-CTLA-4 therapy Meeting Abstract
| Authors: | Chmielowski, B.; Hamid, O.; Minor, D. R.; D'Angelo, S. P.; Pennock, G. K.; Grossmann, K.; Ascierto, P. A.; Daud, A.; Dummer, R.; Hodi, F. S.; Lebbe, C.; Robert, C.; Sosman, J. A.; Yang, A.; Lambert, A.; Weber, J. S. |
| Abstract Title: | A phase III open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator's choice in advanced melanoma patients progressing post anti-CTLA-4 therapy |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419605527 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.TPS9105 |
| Notes: | Meeting Abstract: TPS9105^ -- Source: Wos |
